Albemarle Co. (NYSE:ALB) Shares Bought by Tyers Asset Management LLC

Tyers Asset Management LLC boosted its stake in Albemarle Co. (NYSE:ALB) by 76.0% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,738 shares of the specialty chemicals company’s stock after buying an additional 5,500 shares during the quarter. Tyers Asset Management LLC’s holdings in Albemarle were worth $1,044,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Amundi Pioneer Asset Management Inc. increased its holdings in shares of Albemarle by 0.3% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 176,692 shares of the specialty chemicals company’s stock valued at $14,484,000 after purchasing an additional 460 shares during the last quarter. Neuberger Berman Group LLC grew its position in Albemarle by 46.8% in the first quarter. Neuberger Berman Group LLC now owns 15,066 shares of the specialty chemicals company’s stock worth $1,235,000 after acquiring an additional 4,800 shares during the period. Wilbanks Smith & Thomas Asset Management LLC grew its position in Albemarle by 3.2% in the first quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 4,729 shares of the specialty chemicals company’s stock worth $388,000 after acquiring an additional 146 shares during the period. Commonwealth Equity Services LLC grew its position in Albemarle by 44.1% in the first quarter. Commonwealth Equity Services LLC now owns 49,020 shares of the specialty chemicals company’s stock worth $4,018,000 after acquiring an additional 14,993 shares during the period. Finally, Private Advisor Group LLC grew its position in Albemarle by 49.4% in the first quarter. Private Advisor Group LLC now owns 6,255 shares of the specialty chemicals company’s stock worth $515,000 after acquiring an additional 2,067 shares during the period. Institutional investors own 89.84% of the company’s stock.

Shares of NYSE ALB traded down $1.83 during mid-day trading on Friday, hitting $70.93. The company had a trading volume of 24,656 shares, compared to its average volume of 1,394,859. The stock has a market cap of $7.58 billion, a P/E ratio of 12.94, a PEG ratio of 0.75 and a beta of 1.62. The company has a current ratio of 1.55, a quick ratio of 0.96 and a debt-to-equity ratio of 0.36. Albemarle Co. has a 1-year low of $63.10 and a 1-year high of $108.74.

Albemarle (NYSE:ALB) last posted its quarterly earnings results on Wednesday, May 8th. The specialty chemicals company reported $1.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.02. Albemarle had a return on equity of 15.53% and a net margin of 20.54%. The company had revenue of $832.06 million for the quarter, compared to analysts’ expectations of $827.94 million. During the same period last year, the firm earned $1.30 earnings per share. Albemarle’s quarterly revenue was up 1.3% on a year-over-year basis. On average, equities analysts forecast that Albemarle Co. will post 6.24 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, June 14th will be paid a $0.3675 dividend. This represents a $1.47 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend is Thursday, June 13th. Albemarle’s dividend payout ratio is presently 26.82%.

In other Albemarle news, SVP Deeanne J. Marlow purchased 1,000 shares of the business’s stock in a transaction on Monday, May 13th. The shares were bought at an average cost of $70.85 per share, for a total transaction of $70,850.00. Following the completion of the purchase, the senior vice president now directly owns 1,000 shares in the company, valued at $70,850. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.02% of the stock is owned by company insiders.

A number of research firms have commented on ALB. ValuEngine upgraded Albemarle from a “strong sell” rating to a “sell” rating in a research note on Wednesday. TheStreet cut Albemarle from a “b-” rating to a “c+” rating in a research note on Monday, May 20th. Jefferies Financial Group decreased their price target on Albemarle from $114.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, May 20th. They noted that the move was a valuation call. Loop Capital decreased their price target on Albemarle to $108.00 and set a “buy” rating on the stock in a research note on Thursday, May 16th. Finally, KeyCorp decreased their price target on Albemarle from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Friday, May 10th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $98.98.

TRADEMARK VIOLATION NOTICE: This news story was first published by Markets Daily and is the property of of Markets Daily. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.themarketsdaily.com/2019/06/14/albemarle-co-nysealb-shares-bought-by-tyers-asset-management-llc.html.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.

Further Reading: The basics of gap trading strategies

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.